🔎 Trials Near Me

Home › Delirium › NCT07449416

Ceribell Delirium Monitor Outcomes Pilot Study

Recruiting

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Age is 18 years or older
* Admitted to the ICU for an expected duration ≥ 24 hours from enrollment
* Have at least one of the following conditions:

Acute Sepsis or Septic Shock Admitted to the ICU following elective cardiothoracic surgery Acute respiratory failure requiring non-invasive ventilation or high-flow nasal cannula (HFNC) oxygenation Shock requiring vasopressor therapy Mechanically ventilated - Current RASS ≥ -3 and not expected to require deep sedation (RASS \< -3) during the ICU stay

Exclusion Criteria:

\- Any structural abnormality or head condition, including the presence of a device, that would prevent the use of the Ceribell EEG system for the entire anticipated EEG monitoring period. Examples include: Craniectomy with a missing bone flap in a region where Ceribell EEG electrodes would be placed.

Anticipated use of continuous EEG for a purpose other than delirium detection during the entire expected monitoring period.

* Baseline neurological dysfunction (Glasgow Coma Scale \< 10) and pre-existing brain injuries such as stroke with known deficits, severe TBI
* History of moderate-severe dementia (IQCODE ≥ 3.5)
* APACHE II score \> 30, or SOFA \> 9 at enrollment

About the study

This pilot study is designed as a pre- and post-delirium monitor cohort study, with a prospective intervention cohort and a retrospective control cohort.

What is being tested

Sponsor: Ceribell Inc. · Participants: 100 · Started: Mar 15, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07449416

Locations in the U.S.

CaliforniaUniversity of California Irvine, Irvine
PennsylvaniaUniversity of Pittsburgh Medical Center, Pittsburgh (Not yet recruiting)

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.